Tumor necrosis factor inhibitor therapy and the risk for depression among working-age adults with rheumatoid arthritis

Keyphrases

• Depression Risk 100%
• Rheumatoid Arthritis 100%
• Inhibitor Therapy 100%
• Working Adults 100%
• Tumour Necrosis Factor Inhibitor (TNFi) 100%
• Non-responders 17%
• Treatment Response 11%
• Confidence Interval 5%
• Control Population 5%
• Risk Factors 5%
• Demographic Characteristics 5%
• Systemic Inflammation 5%
• Adjusted Odds Ratio 5%
• Multivariable Logistic Regression 5%
• 1-year Follow-up 5%
• Treatment Effect 5%
• Clinical Characteristics 5%
• Risk Reduction 5%
• Cohort Design 5%
• Treatment Duration 5%
• Medication Use 5%
• Claims Database 5%
• Prescription Drugs 5%
• Low Dose Rate 5%
• Inhibitor Treatment 5%
• Antirheumatic Drugs 5%
• Anti-inflammatory Drugs 5%
• Claims Data 5%
• Observation Period 5%
• Inverse Probability of Treatment Weighting 5%
• Observational Cohort Study 5%
• Weighting Method 5%
• Commercial Claims 5%
• Drug Claims 5%
• Disease-modifying Antirheumatic Drugs (DMARDs) 5%
• Rheumatologic Diseases 5%

Medicine and Dentistry

• Rheumatoid Arthritis 100%
• TNF Inhibitor 100%
• Treatment Response 12%
• Logistic Regression Analysis 6%
• Odds Ratio 6%
• Disease 6%
• Tumor Necrosis Factor 6%
• Drug Therapy 6%
• Antiinflammatory Agent 6%
• Prescription Drug 6%
• Demography 6%
• Cohort Study 6%
• Population Dynamics 6%
• Disease Modifying Antirheumatic Drug 6%

Pharmacology, Toxicology and Pharmaceutical Science

• Rheumatoid Arthritis 100%
• Tumor Necrosis Factor Inhibitor 100%
• Inflammation 6%
• Disease 6%
• Tumor Necrosis Factor 6%
• Prescription Drug 6%
• Cohort Study 6%
• Antiinflammatory Agent 6%
• Disease Modifying Antirheumatic Drug 6%